Ariad gives back gains from rumored Baxalta bid

Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) shed $1.55 (17%) to $7.55 after media reports said Baxalta Inc. (NYSE:BXLT) had abandoned a rumored bid to acquire the biotech. Ariad shares gained $2.91 (42%)...